Glaucoma Trial, Recruiting NCT06976034 Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT06976034
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with an eye condition:

  • Adults between 18 and 80 years old, male or female
  • People who have an eye condition affecting the cornea, the surface of the eye, the lens (such as cataracts), or glaucoma — or who have had or are planning refractive surgery (such as laser eye surgery)
  • People who are covered by French Assurance Maladie (the French public health insurance system)
  • People who have signed a consent form agreeing to take part

For healthy volunteers:

  • Adults between 18 and 80 years old, male or female
  • People with no known conditions that directly or indirectly affect the eyes or eye structures
  • People who are covered by French Assurance Maladie
  • People who have signed a consent form agreeing to take part

Who may not be able to join:

  • People who are unable to keep their head still on a standard chin rest used in eye examinations
  • People who currently have conjunctivitis or another contagious eye condition that is active
  • People who have an implanted pacemaker or other electronic medical device
  • People who have a predisposition to a condition called iridocorneal angle closure (confirm with trial site)
  • People who are considered vulnerable or under legal protection, including pregnant or breastfeeding women, or people under guardianship

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nacim BOUHERAOUA, PU-PH, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

Phone: 00 33 1 40 02 11 44

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Registry
ClinicalTrials.gov
Start date
12 November 2024
Est. completion
12 November 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Image quality; Endothelial cell density; Imaging new corneal and lens structures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov